In Vitro Neutralization of Omicron Variant Serum from vaccinated persons was assayed for
ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two doses …

Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has affected
populations, societies, and lives for more than 2 years. Long-term sequelae of COVID-19, …

Objectives To evaluate the restart of the German Bundesliga (football (soccer)) during the
COVID-19 pandemic from a medical perspective. Methods Participants were male professional …

Background In recent months numerous health care professional acquired COVID-19 at the
workplace resulting in significant shortages in medical and nursing staff. We investigated …

Convalescent Antibodies after Omicron Infection Although considerable data show cross-reactivity
among antibodies generated by infection with the various SARS-CoV-2 variants of …

Several studies have shown that SARS-CoV-2 BA.1 omicron is an immune escape variant.
Meanwhile, however, omicron BA.2 and BA.5 became dominant in many countries and …

Neutralizing antibodies are a major correlate of protection for many viruses including the
novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce neutralizing …

Since emergence of the initial SARS-CoV-2 BA.1, BA.2 and BA.5 variants, Omicron has
diversified substantially. Antigenic characterization of these new variants is important to analyze …

Background Several COVID-19 vaccines have been approved. The mRNA vaccine from
Pfizer/BioNTech (Comirnaty, BNT162b2; BNT) and the vector vaccine from AstraZeneca (…

Background Correlates of protection could help to assess the extent to which a person is
protected from SARS-CoV-2 infection after vaccination (so-called breakthrough infection). We …